‘The Dropout‘ takes viewers on a journey through the rise and demise of Theranos, a biotech company.
The storey follows Elizabeth Holmes (Amanda Seyfried) as she leaves Stanford to find Theranos. However, the corporation is having a hard time following through on its promises and claims.
Holmes partners with Walgreens and contacts Dr. Jay Rosan with a proposal in order to develop an income stream for Theranos. Because the show is based on true events, viewers must be curious about Rosan and his current whereabouts.
Allow us to share whatever we know about Dr. Jay Rosan in that situation!
In ‘The Dropout’, Who is Dr. Jay Rosan?
In the 4th episode of ‘The Dropout,’ Dr. Jay Rosan is introduced. He is the Medical Director of Walgreens, where he works on health-related innovation projects.
Rosan is approached by Elizabeth Holmes about a possible relationship between Theranos and Walgreens.
According to the agreement, Theranos will open wellness centres in Walgreens stores for quick and easy blood testing.
Rosan is taken aback by Holmes’ demeanour and work at Theranos. As a result, he chooses to forward Holmes’ proposal to his company’s CFO.
In ‘The Dropout,’ actor Alan Ruck portrays Dr. Jay Rosan. Ruck is a veteran actor who first appeared on television in 1983.
He is recognised for his roles in ‘Freaky,’ ‘Ferris Bueller’s Day Off,’ and ‘Spin City,’ among other popular shows and films. Ruck played Connor Roy in HBO’s hit dark comedy ‘Succession,’ and fans of the show will know him.
In ‘The Dropout,’ Ruck’s character is based on a real person with the same name. Dr. Jay Rosan was one of the major figures in finalising the transaction between Theranos and Walgreens, as dramatised in the series and recounted in John Carreyrou’s non-fiction book ‘Bad Blood.’
Where Is Walgreens’ Ex-Medical Director ‘Dr. Jay Rosan’ Today?
In 2014, the Walgreens-Theranos partnership became operational. However, flaws with Theranos’ test results quickly surfaced, prompting Walgreens to terminate its agreement with the business in 2016.
Theranos eventually went bankrupt and was dissolved in 2018. Walgreens sued Theranos in 2016, demanding $140 million in damages for breach of contract. The case was settled for a sum of money that was less than $30 million.
Holmes was charged with fraud, and her trial was completed in 2022. Her sentencing is now pending.
Dr. Jay Rosan, on the other hand, stayed at Walgreens for several years after the company’s partnership with Theranos terminated. He spent the majority of his career as a Vice President of Health Innovation at Walgreens.
He was also a part of the Walgreens Innovation Network. Rosan is well-known for being one of the HMO of Pennsylvania’s initial medical directors. In addition, he is a co-founder of Medovation.
Rosan was recently appointed to the board of directors of Group K Diagnostics (GKD), a firm that focuses on biological inventions.
The headquarters of the corporation are in Philadelphia, Pennsylvania. As a result, Rosan is most likely based in Philadelphia.